F-group (family)
315.1.1.1 MIF
Ligands and drugs
703
Member domains
456
with ligand contacts (≤ 4 Å)
64.9% of members
410
with DrugDomain annotations
58.3% of members
339
with a DrugBank compound
48.2% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 315.1.1.1 belongs to X-group 315 Tautomerase/MIF-like, which binds 10.2 ligand superclasses per 20 proteins, broader than 95% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB07718 | ENO | 4-Hydroxyphenylpyruvic acid | 8 |
| DB09459 | TLA | L-tartaric acid | 6 |
| DB00695 | FUN | Furosemide | 3 |
| DB01148 | HWL | Flavoxate | 3 |
| DB02375 | MYC | Myricetin | 3 |
| DB02384 | FHC | (E)-2-Fluoro-P-Hydroxycinnamate | 3 |
| DB02728 | YZ9 | 7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester | 3 |
| DB03297 | PMS | Benzylsulfonic acid | 3 |
| DB07888 | HDI | 3-(4-HYDROXYPHENYL)-4,5-DIHYDRO-5-ISOXAZOLE-ACETIC ACID METHYL ESTER | 3 |
| DB08333 | OX3 | 4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME | 3 |
| DB08334 | OX4 | 3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME | 3 |
| DB08335 | OX5 | 4-HYDROXYBENZALDEHYDE O-(3,3-DIMETHYLBUTANOYL)OXIME | 3 |
| DB08765 | ZEC | 6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE | 3 |
| DB01880 | DHC | 3,4-Dihydroxycinnamic Acid | 2 |
| DB05266 | AVL | Ibudilast | 2 |
| DB16770 | MRI | Morin | 2 |
| DB00119 | PYR | Pyruvic acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 93 |
| NAmetal | SODIUM ION | 23 |
| 3TX | 4-[4-(quinolin-2-yl)-1H-1,2,3-triazol-1-yl]phenol | 12 |
| ENO | 3-(4-HYDROXY-PHENYL)PYRUVIC ACID | 12 |
| RW1 | 4-phenylpyrimidine | 10 |
| EN1 | (2E)-2-hydroxy-3-(4-hydroxyphenyl)prop-2-enoic acid | 9 |
| 9BE | N-benzylthioformamide | 6 |
| AVR | (2R)-2-amino-1-[2-(1-methylethyl)pyrazolo[1,5-a]pyridin-3-yl]propan-1-one | 6 |
| LE2 | N-(2-phenylethyl)thioformamide | 6 |
| TLA | L(+)-TARTARIC ACID | 6 |
| ZNmetal | ZINC ION | 6 |
| CAmetal | CALCIUM ION | 4 |
| 0FI | N-phenylthioformamide | 3 |
| 0IN | 7-(pyridin-3-ylmethyl)quinolin-8-ol | 3 |
| 1Q2 | (4R,6Z)-6-(3-fluoro-4-hydroxyphenyl)-4-hydroxy-6-iminohexan-2-one | 3 |
| 1X2 | 6-isothiocyanatohexylbenzene | 3 |
| 1ZW | N-[(4-cyanophenyl)methyl]methanethioamide | 3 |
| 2OK | 4-(3-methoxy-5-methylphenoxy)-2-(4-methoxyphenyl)-6-methylpyridine | 3 |
| 30Y | (2R)-3-[(2-chlorophenyl)amino]-2-cyano-3-thioxo-N-[3-(trifluoromethyl)phenyl]propanamide | 3 |
| 31E | (Z)-[(furan-2-ylmethyl)imino]methanethiol | 3 |